UBRIGENE
Ubrigene is driven by the advancement of gene and cell therapy technologies through research and development represented by AAV vectors. It can provide a comprehensive solution for gene therapy industrialization.
UBRIGENE
Social Links:
Industry:
Biotechnology
Founded:
2015-01-01
Address:
Miyun, Beijing, China
Country:
China
Website Url:
http://www.ubrigene.com
Total Employee:
501+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
67.97 M USD
Technology used in webpage:
Organization Schema Person Schema Google Google Cloud
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
Current Employees Featured
Founder
Investors List
FOF Capital
FOF Capital investment in Series C - uBriGene
Jinan Industrial Development Group
Jinan Industrial Development Group investment in Series C - uBriGene
Guotai Junan Innovation Investment
Guotai Junan Innovation Investment investment in Series C - uBriGene
Jinshi Investment
Jinshi Investment investment in Series C - uBriGene
CLSA
CLSA investment in Series C - uBriGene
FOF Capital
FOF Capital investment in Series C - uBriGene
Wenzhou Dongchuang Xinhui
Wenzhou Dongchuang Xinhui investment in Series C - uBriGene
Huagai Capital
Huagai Capital investment in Series C - uBriGene
IDG Capital
IDG Capital investment in Series C - uBriGene
Yanchuang Capital
Yanchuang Capital investment in Series C - uBriGene
Official Site Inspections
http://www.ubrigene.com
- Host name: ec2-54-219-239-177.us-west-1.compute.amazonaws.com
- IP address: 54.219.239.177
- Location: San Jose United States
- Latitude: 37.3388
- Longitude: -121.8914
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 95141
More informations about "uBriGene"
About Us - uBriGene
About uBriGene. With extensive experience in ATMPs, uBriGene is globally recognized for its biotechnological development and manufacturing expertise. By integrating a collaborative mindset with innovative solutions, we catalyze …See details»
Team - uBriGene
She established CMC organization from the scratch at MINK including Process/Analytical Development, internal cGMP production capability, QC testing laboratories as well as supply chain management, etc. ... He joined uBriGene …See details»
uBriGene - Crunchbase Company Profile & Funding
Organization. uBriGene . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... This acquisition is a …See details»
uBriGene Biosciences International Co., Author at Life Sciences …
UBriGene Biosciences International Co. Website www.ubrigene.com; Phone +1 (604) 227 7066 Email [email protected]; Address 1255-13351 Commerce Parkway Richmond, BC V6V 2X7; …See details»
Breaking News: UbriGene Biosciences Inc Secures $200 Million for ...
Dec 25, 2024 UbriGene Biosciences Inc. is thrilled to announce that it has successfully raised $200 million in its latest funding round, a pivotal milestone that will further propel its mission to …See details»
uBriGene Appoints Dr. Joy Zhou to Lead Cell Therapy Development
1 day ago China-based advanced therapy medicinal product (ATMP) contract development and manufacturing organization (CDMO) uBriGene Biosciences announced the appointment of Dr. …See details»
uBriGene Biosciences Inc. - VentureRadar
" uBriGene is a leading Contract Development and Manufacturing Organization (CDMO) specializing in the development and commercialization of Advanced Therapy Medicinal …See details»
Cell and Gene Therapy CDMO Targets North American Growth …
UBriGene, a cell & gene therapy contract development and manufacturing organization (CDMO), is expanding into the US market with the acquisition of a state-of-the-art GMP manufacturing …See details»
Targets North American growth with major acquisition - uBriGene
Cell and gene therapy CDMO targets North American growth with major US acquisition. uBriGene Biosciences Inc. (uBrigene), a cell & gene therapy contract development and manufacturing …See details»
Cell therapy weekly: uBriGene moves into the US …
May 25, 2023 UBriGene moves into the US market with GMP facility acquisition. The cell and gene therapy contract development and manufacturing organization (CDMO), uBriGene (Vancouver, Canada), has expanded into the US market …See details»
uBriGene Expands into US Market with Acquisition of Mustang
May 23, 2023 Mustang Bio, a US-based clinical-stage biopharmaceutical company, announced on May 18, 2023 that it has entered into an agreement with uBriGene Biosciences, the US …See details»
uBriGene Biosciences Inc. closes 150 million CNY (20 million USD ...
Apr 27, 2023 September 2021: uBriGene raised nearly 200 million CNY (29 million USD) capital in Round B financing, which was used to improve viral vector manufacturing technologies, to …See details»
Ubrigene 2025 Company Profile: Valuation, Funding & Investors
Ubrigene General Information Description. Provider of gene and cell therapy contract research services intended to assist drug development companies. The company's research focuses on …See details»
Cell and Gene Therapy CDMO Targets North American Growth …
May 19, 2023 uBriGene, a cell & gene therapy contract development and manufacturing organization (CDMO), is expanding into the US market with the acquisition of a state-of-the-art …See details»
Contact Us - uBriGene
UBriGene Biosciences Inc. is committed to building a national marketing network that brings convenient, intelligent services to our customers, and delivers accurate, safe technology to the …See details»
Cell and Gene Therapy CDMO Makes Major US Acquisition
May 19, 2023 uBriGene, a cell & gene therapy contract development and manufacturing organization (CDMO), is expanding into the US market with the acquisition of a state-of-the-art …See details»
uBriGene Biosciences Inc. - BIO International Convention | BIO
UBriGene Bioscience Inc. is a leading contract development and manufacturing organization (CDMO), specializing in development and application of cell and gene therapy technologies. uBriGene provides clients with end-to-end cell and gene therapy support.See details»
UBriGene Biosciences collects $20m in Series C-plus financing
May 3, 2023 Vancouver-based uBriGene Biosciences, a provider of one-stop contract development and manufacturing organization (CDMO) services for cell and gene therapy, has …See details»
Cell & Gene Therapy CDMO Targets North American Growth With …
UBriGene is expanding into the US market with the acquisition of a state-of-the-art GMP manufacturing facility from NASDAQ-listed company Mustang Bio, Inc. The cell & gene …See details»